Pfizer names Dr. Chris Boshoff as new Chief Scientific Officer, taking over in January 2025.

Pfizer has appointed Chris Boshoff, M.D., PhD, as its new Chief Scientific Officer and President of Research & Development, starting January 1, 2025. Boshoff, who was previously the Chief Oncology Officer and Executive Vice President, will succeed Dr. Mikael Dolsten and will report to Pfizer's CEO, Dr. Albert Bourla. In his new role, he will oversee all R&D activities across all therapeutic areas.

November 20, 2024
16 Articles